TrialAIDS patient care and STDs2012

A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.

Jordan E Lake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.